
Overview
Adam M. Brufsky, MD, PhD, FACP, is professor of medicine at the University of Pittsburgh School of Medicine and also serves as the associate division chief for the Division of Hematology/Oncology at the University of Pittsburgh School of Medicine's Department of Medicine. Dr. Brufsky is the medical director of the Magee-Women's Cancer Program, part of the UPMC Hillman Cancer Center, and UPMC Hillman Cancer Center; associate director for clinical investigations at UPMC Hillman Cancer Center; and codirector of the Comprehensive Breast Cancer Center. Dr. Brufsky is board-certified in internal medicine and medical oncology. He earned a medical and doctor of philosophy degrees from the University of Connecticut School of Medicine in Farmington, Conn.; completed a residency at Brigham and Women's Hospital, Harvard Medical School, and a fellowship at Dana-Farber Cancer Institute. Dr. Brufsky is a member of professional organizations, such as American Medical Association, Massachusetts Medical Society, American College of Physicians, American Society of Clinical Oncology, American Association for Cancer Research, Allegheny County Medical Society, Pennsylvania Medical Society, and Pennsylvania Oncologic Society. An active researcher, Dr. Brufsky has numerous abstracts and research articles in leading journals, and is principal investigator on a number of research grants funded by the National Institutes of Health, Susan G. Komen Foundation, and US Army - Breast Cancer Research Program.
Dr. Brufsky is rated as an Advanced provider by MediFind in the treatment of Caffey Disease. His top areas of expertise are Breast Cancer, Triple-Negative Breast Cancer, Inflammatory Breast Cancer, Breast Cancer in Men, and Gastrostomy.
His clinical research consists of co-authoring 331 peer reviewed articles and participating in 45 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- INSURANCE PLAN
- HMO
- MANAGED MEDICAID PLAN
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
300 Halket Street, Suite 4628, Pittsburgh, PA 15213
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
39 Clinical Trials
UPMC Hillman Cancer Center
Priya Rastogi, MD, is currently Associate Professor of Medicine at the University of Pittsburgh School of Medicine. Dr. Rastogi received a Bachelor of Arts degree in Chemistry from Miami University at Oxford, Ohio. She earned her MD at Wright State University School of Medicine in Dayton, Ohio and completed her residency in Internal Medicine at Saint Joseph's Hospital in Denver, Colorado, where she received the Resident of the Year Award. Her Fellowship was completed at the University of Pittsburgh School of Medicine in Pittsburgh, PA. During her fellowship, Dr. Rastogi's research was focused on Herceptin-induced cardiotoxicity, and she was awarded a grant from the National Surgical Breast and Bowel Project. Dr. Rastogi is board certified in Internal Medicine and Medical Oncology by the American Board of Internal Medicine. She is an associate member of the American Society of Clinical Oncology and the American Association for Cancer Research. She has several abstracts and research articles in leading journals, including Seminars in Breast Disease, Oncology, and Diseases of the Breast. Dr. Rastogi practices in the Womens Cancer Center at Magee-Womens Hospital will see over 125 new breast cancer consultations and over 1250 patient visits in 2004. Dr. Rastogi has participated in the Introduction to Being a Physician course for first year medical students at the University of Pittsburgh School of Medicine for two years and is also active within the community for lectures and presentations. Dr. Rastogi is rated as an Advanced provider by MediFind in the treatment of Caffey Disease. Her top areas of expertise are Breast Cancer, Inflammatory Breast Cancer, Paget Disease of the Breast, and Caffey Disease.
UPMC Hillman Cancer Center
Shannon L. Puhalla, MD, is assistant professor of medicine at the University of Pittsburgh School of Medicine, and a medical oncologist and hematologist at UPMC Hillman Cancer Center. She specializes in breast oncology, Phase I clinical trials, and novel therapeutics in breast cancer. Dr. Puhalla is rated as a Distinguished provider by MediFind in the treatment of Caffey Disease. Her top areas of expertise are Inflammatory Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Breast Cancer.
UPMC Hillman Cancer Center
Vikram C. Gorantla, MD, specializes in the treatment of sarcoma, breast cancer, gastrointestinal malignancies, and head and neck cancers. Board-certified in internal medicine and medical oncology, he received his medical degree at the University of Texas Southwestern Medical School in Dallas. He completed his internal medicine residency at Washington University, St. Louis, MO, and his hematology/oncology fellowship at UPMC. Dr. Gorantla has a dedicated day seeing breast cancer patients at the Magee-Womens Cancer Progam. He also collaborates with surgical oncologists and gynecologists/oncologists to provide multidisciplinary care to patients. Dr. Gorantla is rated as a Distinguished provider by MediFind in the treatment of Caffey Disease. His top areas of expertise are Breast Cancer, Paget Disease of the Breast, Ampullary Cancer, Gamma Knife Radiosurgery, and Endoscopy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Breast CancerDr. Brufsky isElite. Learn about Breast Cancer.
- Triple-Negative Breast CancerDr. Brufsky isElite. Learn about Triple-Negative Breast Cancer.
- Distinguished
- AngiosarcomaDr. Brufsky isDistinguished. Learn about Angiosarcoma.
- Breast Cancer in MenDr. Brufsky isDistinguished. Learn about Breast Cancer in Men.
- Inflammatory Breast CancerDr. Brufsky isDistinguished. Learn about Inflammatory Breast Cancer.
- Paget Disease of the BreastDr. Brufsky isDistinguished. Learn about Paget Disease of the Breast.
- Advanced
- AgranulocytosisDr. Brufsky isAdvanced. Learn about Agranulocytosis.
- Bone TumorDr. Brufsky isAdvanced. Learn about Bone Tumor.
- Brain TumorDr. Brufsky isAdvanced. Learn about Brain Tumor.
- Caffey DiseaseDr. Brufsky isAdvanced. Learn about Caffey Disease.
- Febrile NeutropeniaDr. Brufsky isAdvanced. Learn about Febrile Neutropenia.
- HER2 Negative Breast CancerDr. Brufsky isAdvanced. Learn about HER2 Negative Breast Cancer.
- Experienced
- ALK-Positive Non-Small Cell Lung CancerDr. Brufsky isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Anal CancerDr. Brufsky isExperienced. Learn about Anal Cancer.
- AnemiaDr. Brufsky isExperienced. Learn about Anemia.
- ChondrosarcomaDr. Brufsky isExperienced. Learn about Chondrosarcoma.
- Chronic Familial NeutropeniaDr. Brufsky isExperienced. Learn about Chronic Familial Neutropenia.
- DICER1 SyndromeDr. Brufsky isExperienced. Learn about DICER1 Syndrome.



